loading
前日終値:
$42.44
開ける:
$42.54
24時間の取引高:
442.11K
Relative Volume:
0.70
時価総額:
$1.74B
収益:
$17.39M
当期純損益:
$-135.89M
株価収益率:
-8.944
EPS:
-4.64
ネットキャッシュフロー:
$-123.00M
1週間 パフォーマンス:
-4.05%
1か月 パフォーマンス:
+3.23%
6か月 パフォーマンス:
-14.92%
1年 パフォーマンス:
+46.95%
1日の値動き範囲:
Value
$40.75
$42.54
1週間の範囲:
Value
$40.75
$43.55
52週間の値動き範囲:
Value
$20.08
$57.28

Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile

Name
名前
Tarsus Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
(949) 409-9820
Name
住所
15440 LAGUNA CANYON ROAD, IRVINE
Name
職員
323
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
TARS's Discussions on Twitter

TARS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TARS
Tarsus Pharmaceuticals Inc
41.50 1.78B 17.39M -135.89M -123.00M -4.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-02 再開されました Oppenheimer Outperform
2025-05-27 再開されました H.C. Wainwright Buy
2023-11-20 開始されました Goldman Neutral
2023-07-18 開始されました William Blair Outperform
2023-05-18 開始されました Guggenheim Buy
2022-08-01 開始されました Barclays Overweight
2021-12-21 開始されました H.C. Wainwright Buy
2021-11-23 開始されました Oppenheimer Outperform
2020-11-10 開始されました BofA Securities Buy
2020-11-10 開始されました Jefferies Buy
2020-11-10 開始されました Ladenburg Thalmann Buy
2020-11-10 開始されました Raymond James Strong Buy
すべてを表示

Tarsus Pharmaceuticals Inc (TARS) 最新ニュース

pulisher
Jul 25, 2025

Bank of New York Mellon Corp Sells 915 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Tarsus Pharmaceuticals Inc. stock before earningsHigh-yield investments - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

When is the best time to buy Tarsus Pharmaceuticals Inc. stockHigh-yield market plays - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Tarsus Pharmaceuticals Inc. a good long term investmentOutstanding growth strategies - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Tarsus Pharmaceuticals Inc. Stock Analysis and ForecastHigh-return market picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Tarsus Pharmaceuticals Inc. stockHigh-yield portfolio picks - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Arizona State Retirement System Purchases 470 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Tarsus Pharmaceuticals Inc. stock priceBreakthrough wealth creation - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Tarsus Pharmaceuticals Inc. stock price move sharplyFree Stock Movement Tracking - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Tarsus Pharmaceuticals (TARS) and Abbott Laboratories (ABT) - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

Tarsus Pharmaceuticals Shares Soar 4.47% on Strong Sales, Earnings - AInvest

Jul 18, 2025
pulisher
Jul 17, 2025

Tarsus Pharmaceuticals: A Compelling Case for Investment in the Era of Anterior Segment Innovation - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

William Blair Has Bearish Estimate for TARS Q2 Earnings - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

What is William Blair’s Forecast for TARS FY2026 Earnings? - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

How Tarsus Pharmaceuticals Inc. stock performs during market volatilityFree Investment Risk Control - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Tarsus Pharmaceuticals Inc. stock attracts strong analyst attentionHigh Return Potential - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Bank of America Securities Reaffirms Buy Rating for Tarsus Pharmaceuticals at $68.00 - AInvest

Jul 13, 2025
pulisher
Jul 12, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Amalgamated Bank - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Analysts - Defense World

Jul 12, 2025
pulisher
Jul 08, 2025

(TARS) Investment Analysis - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 02, 2025

Market Sentiment Around Loss-Making Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - simplywall.st

Jul 02, 2025
pulisher
Jul 01, 2025

Janney Montgomery Scott LLC Sells 2,795 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jul 01, 2025
pulisher
Jun 30, 2025

Tarsus Pharmaceuticals, Inc.(NasdaqGS:TARS) dropped from Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 19, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) versus Protalix BioTherapeutics (NYSE:PLX) Financial Comparison - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

When (TARS) Moves Investors should Listen - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 17, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus

Jun 12, 2025

Tarsus Pharmaceuticals Inc (TARS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):